Cargando…
Inflammation exerts a nonrandom risk in the acquisition and progression of the MPN: Insights from a Mendelian randomization study
Autores principales: | Karantanos, Theodoros, Kaizer, Hannah, Chaturvedi, Shruti, Resar, Linda M.S., Moliterno, Alison R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167502/ https://www.ncbi.nlm.nih.gov/pubmed/32322810 http://dx.doi.org/10.1016/j.eclinm.2020.100324 |
Ejemplares similares
-
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
por: Spivak, Jerry L., et al.
Publicado: (2021) -
American Society of Hematology 2020 Podcast Collection: MPN
por: Breccia, Massimo
Publicado: (2021) -
Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis
por: Dalton, William Brian, et al.
Publicado: (2022) -
JAK2(V617F) allele burden in polycythemia vera: burden of proof
por: Moliterno, Alison R., et al.
Publicado: (2023) -
Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology
por: Karantanos, Theodoros, et al.
Publicado: (2021)